Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04601961
What this trial is testing

Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

Who this might be right for
Circulating Tumor CellHepatocellular Carcinoma
The University of Hong Kong 220
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Not applicableLooking for participantsNCT07351669
What this trial is testing

Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaTACE(Transcatheter Arterial Chemoembolization)CT
Zhongda Hospital 121
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Early research (Phase 1)Ended earlyNCT00823290
What this trial is testing

Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Erlangen-Nürnberg Medical School 2
Very early researchEnded earlyNCT04601428
What this trial is testing

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center 12
Not applicableLooking for participantsNCT03686709
What this trial is testing

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

Who this might be right for
Hepatocellular CarcinomaRadiation Exposure
University of Tennessee 20
Not applicableStudy completedNCT05233098
What this trial is testing

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 6
Not applicableUnknownNCT03594929
What this trial is testing

Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery

Who this might be right for
Hepatocellular Cancer
Singapore General Hospital 50
Large-scale testing (Phase 3)UnknownNCT05056337
What this trial is testing

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 220
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Not applicableActive Not RecruitingNCT06141564
What this trial is testing

Detect and Expunge Concealed Tumors of the Liver

Who this might be right for
Liver Cancer
Johns Hopkins University 360
Testing effectiveness (Phase 2)Looking for participantsNCT07223307
What this trial is testing

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Who this might be right for
Liver CancerIntrahepatic CholangiocarcinomaLiver Metastases+1 more
Stanford University 62
Not applicableNot Yet RecruitingNCT04053231
What this trial is testing

Hepatocarcinoma Recurrence on the Liver Study - Part2

Who this might be right for
Liver CancerSurgeryRecurrence Tumor+1 more
University of Milano Bicocca 3,000
Not applicableUnknownNCT03985644
What this trial is testing

Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
HCCLiver Transplantation
Zhejiang University 500
Testing effectiveness (Phase 2)Looking for participantsNCT07014150
What this trial is testing

Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Resectable
Peking Union Medical College Hospital 33
Large-scale testing (Phase 3)UnknownNCT03500380
What this trial is testing

RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Who this might be right for
Breast NeoplasmsBreast DiseasesCapecitabine+3 more
RemeGen Co., Ltd. 301
Testing effectiveness (Phase 2)WithdrawnNCT03563170
What this trial is testing

QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma Recurrent
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Next Page